Viewing nowAstein Tablet 20 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Kyungbo Pharmaceutical Co., Ltd.

MFDS item code 201501997 · Approved 2015.04.13 · Insurance code 665001930
Improvement of hyperlipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
This medication helps to reduce the risk of cardiovascular diseases. It lowers the risk of myocardial infarction and stroke and helps to prevent cardiovascular issues such as vascular surgeries and angina. Additionally, it reduces the risk of heart disease in patients with diabetes. It is also used to treat hyperlipidemia by lowering cholesterol and triglycerides while increasing good cholesterol (HDL), thereby improving blood lipid status. It is specifically applicable to pediatric patients with familial hypercholesterolemia to lower their risk of heart disease. Through these effects, it is used to improve cardiovascular health and reduce the risk of heart diseases.
1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered at a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to patient characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after initiation of treatment and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, measurement of LDL cholesterol is recommended when initiating treatment and evaluating response. If LDL cholesterol levels are unavailable, total cholesterol should be used to monitor response to treatment. Patients with homozygous familial hypercholesterolemia This drug is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Elderly patients: The efficacy and safety in patients 70 years of age or older are similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on administering doses greater than 20 mg of this drug in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.
This medication may pose a risk of muscle problems; therefore, if symptoms such as muscle pain or muscle weakness occur, notify your doctor immediately. In particular, if muscle enzyme levels are elevated or myopathy is suspected, the use of this medication should be discontinued. Patients with liver function issues or active liver disease should not take this medication. Women who are pregnant or may become pregnant, as well as breastfeeding women, should not use this medication. Children under the age of 10 should not take this medication, and adolescents aged 10 and over should take it under a doctor's guidance. Individuals with a history of alcohol abuse or liver disease should use this medication cautiously, and regular liver function tests are required. Elderly individuals have a higher risk of developing myopathy, so muscle condition should be carefully monitored when taking this medication. There are many interactions with other drugs, so caution is needed when taken with certain antibiotics, antifungals, antivirals, antihypertensives, antidiabetics, etc. Particularly, grapefruit juice can increase the blood concentration of this medication, raising the risk of side effects, so excessive intake should be avoided. If symptoms such as muscle pain, muscle weakness, fatigue, or fever occur, consult medical personnel immediately, and if necessary, perform blood tests to check muscle enzyme levels. It is important to regularly check liver function and muscle condition while taking this medication. For proper storage, keep it out of reach of children and store it in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, preferably at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent degradation.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Kyungbo Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.